12-1028211-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_178040.4(ERC1):āc.308G>Cā(p.Arg103Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,614,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.00011 ( 0 hom., cov: 32)
Exomes š: 0.00011 ( 1 hom. )
Consequence
ERC1
NM_178040.4 missense
NM_178040.4 missense
Scores
6
8
4
Clinical Significance
Conservation
PhyloP100: 9.71
Genes affected
ERC1 (HGNC:17072): (ELKS/RAB6-interacting/CAST family member 1) The protein encoded by this gene is a member of a family of RIM-binding proteins. RIMs are active zone proteins that regulate neurotransmitter release. This gene has been found fused to the receptor-type tyrosine kinase gene RET by gene rearrangement due to the translocation t(10;12)(q11;p13) in thyroid papillary carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.043040693).
BP6
Variant 12-1028211-G-C is Benign according to our data. Variant chr12-1028211-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 3054082.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 16 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERC1 | NM_178040.4 | c.308G>C | p.Arg103Pro | missense_variant | 2/19 | ENST00000360905.9 | NP_829884.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERC1 | ENST00000360905.9 | c.308G>C | p.Arg103Pro | missense_variant | 2/19 | 1 | NM_178040.4 | ENSP00000354158.3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152120Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
16
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000266 AC: 67AN: 251474Hom.: 1 AF XY: 0.000250 AC XY: 34AN XY: 135908
GnomAD3 exomes
AF:
AC:
67
AN:
251474
Hom.:
AF XY:
AC XY:
34
AN XY:
135908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000107 AC: 157AN: 1461892Hom.: 1 Cov.: 32 AF XY: 0.000125 AC XY: 91AN XY: 727248
GnomAD4 exome
AF:
AC:
157
AN:
1461892
Hom.:
Cov.:
32
AF XY:
AC XY:
91
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74430
GnomAD4 genome
AF:
AC:
16
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
32
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ERC1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D;.;.;.;D;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;L;.;L;L;L;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;.;.;D;.;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;.;.;D;.;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D
Polyphen
D;.;D;.;.;D;D;.
Vest4
MutPred
Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);Gain of catalytic residue at V102 (P = 2e-04);
MVP
MPC
1.3
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at